- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05603988
Evaluation of The Effect of 980nm Diode Laser Intracanal Irradiation on Levels of Interleukin-8 Expression
Evaluation of The Effect of 980nm Diode Laser Intracanal Irradiation on Levels of Interleukin-8 Expression in Lesions Refractory to Endodontic Treatment: A Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Thorough medical and dental history for the eligible patients
- Thorough intraoral and extraoral diagnosis
- Local anesthesia
- Isolation and removal of any previous filling or restoration
- Removal of old gutta percha and establish patency to the full working length.
- 1st sample: will be collected using 3 sterile paper points
- Chemo-mechanical preparation.
2nd sample collection
• Laser group: The canals will be irradiated with a high-power diode laser, with wavelength of 980 nm, maximum output of 3 watts and coupled with a fiber optic tip of 200 µm diameter.
• Mock laser application (Placebo group): The fiberoptic tip will be inserted inside the root canal, mimicking the laser irradiation, but not activated.
- 3rd sample collection
- A piece of dry cotton will be placed in the access cavity, and then will be sealed with glass ionomer filling material
- 2nd visit: 1 week later, 4th sample collection then Obturation
- Number of visits & follow up period: Two visits
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11553
- Faculty of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- failed previously treated endodontic single-rooted teeth with chronic periapical lesions; with radiographic evidence of periapical radiolucency of not less than 1 cm diameter will be selected.
- Teeth with straight root canals.
- No contributory medical history.
- No previous administration of analgesics and/or antibiotics within the previous 2 weeks.
Exclusion Criteria:
- Retreatment cases with complications such as separated instruments, perforations, ledges, resorption, transportation, calcifications, immature apices and over fillings.
- Teeth with curved roots.
- Swelling or sinus tract.
- Mutilated teeth that interfere with proper isolation and seal between visits.
- Subjects with generalized periodontitis, or if the tooth has a probing depth of more than 3 mm.
- Subjects with uncontrolled diabetes or debilitating diseases.
- Pregnant or nursing females.
- Systemic disorders that necessitate antibiotic prophylaxis or prevent the use of Ibuprofen.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo group
• Mock laser application (Placebo group): The fiber optic tip will be inserted inside the root canal, mimicking the laser irradiation group, but not activated
|
After endodontic retreatment, mock laser application (Placebo group) will be applied: The fiberoptic tip will be inserted inside the root canal, mimicking the laser irradiation group, but not activated |
Other: Diode Laser group
Intracanal Diode laser application
|
After endodontic retreatment, root canals will be irradiated with a 980 nm diode laser coupled with optical fibre 200 μm (Litemedics, Italy) with setting 1.2-watt power, in pulsed mode.
The irradiation protocol will be of 5-sec irradiation followed by a 10-sec pause, which constituted one lasing cycle.
The lasing cycle will be performed four times for each tooth.
The tip will be positioned 1 mm short of the apex.
Followed by activation during which it will be slowly dragged at a speed of approximately 2 mm/ sec in a way that the root canals will be irradiated from the apical to the coronal portion, in a helicoidal movement touching the canal walls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
quantification of IL-8
Time Frame: one week
|
- After collection of all the samples, quantification of IL-8 will be determined using ELISA kit before (S-1), after chemo-mechanical preparation (S-2), after intracanal irradiation or placebo effect (S-3) and last after one week of the treatment (S-4).
The kit is used according to the manufacturer's recommendations.
|
one week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative pain
Time Frame: 6, 12, 24 hours and 7 days
|
Following the first visit, the modified visual analogue scale (VAS scale) with 11 points where 0 means no pain and 10 means maximum pain will be used to record patient's level of pain
|
6, 12, 24 hours and 7 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dina A Morsy, lecturer, Cairo University
- Principal Investigator: Sherif A Elkhodary, assoc. Prof, Cairo University
Publications and helpful links
General Publications
- Morsy DA, Negm M, Diab A, Ahmed G. Postoperative pain and antibacterial effect of 980 nm diode laser versus conventional endodontic treatment in necrotic teeth with chronic periapical lesions: A randomized control trial. F1000Res. 2018 Nov 15;7:1795. doi: 10.12688/f1000research.16794.1. eCollection 2018.
- Kamma JJ, Vasdekis VG, Romanos GE. The effect of diode laser (980 nm) treatment on aggressive periodontitis: evaluation of microbial and clinical parameters. Photomed Laser Surg. 2009 Feb;27(1):11-9. doi: 10.1089/pho.2007.2233.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAMorsy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endodontically Treated Teeth
-
Susana MorimotoCompletedCeramic Restorations in Endodontically Treated TeethBrazil
-
Cukurova UniversityCompletedEndodontically-Treated Teeth
-
Cairo UniversityUnknownEndodontically-Treated Teeth | Spacing of Anterior Maxillary Teeth | Broken Teeth Injury With ComplicationEgypt
-
Cairo UniversityUnknownBadly Decayed Teeth andTeeth Restored With Large Filling Restorations and Endodontically Treated Teeth and Malformed Teeth and Malposed Teeth
-
Cairo UniversityUnknown
-
Cairo UniversityRecruitingEndodontically Treated Teeth | Posterior Teeth | Worn Posterior Teeth | Crowned Posterior TeethEgypt
-
Cairo UniversityUnknownSingle Posterior Crowns | Badly Decayed Teeth, Teeth Restored With Large Filling Restorations or Endodontically Treated Teeth | Malformed Teeth, Malposed Teeth (Tilted, Over-erupted, Rotated, Etc.) or Spacing Between Posterior Teeth
-
Kafrelsheikh UniversityCompletedEndodontically Treated Teeth | Anterior TeethEgypt
-
SeptodontQualityStat; ReCOL; EndoDataRecruitingEndodontically Treated TeethFrance
-
Cairo UniversityCompletedEndodontically Treated TeethEgypt
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States